State of the Art: Brugada Syndrome Novel diagnostic approaches and risk stratification

Similar documents
Tailored treatment in Brugada syndrome

Invasive Risk Stratification: When is it needed?

Ripolarizzazione precoce. Torino, 24th October Non così innocente come si pensava

Are there low risk patients in Brugada syndrome?

Διαχείρηση Ασυμπτωματικού ασθενούς με ΗΚΓ τύπου Brugada

Prevention of Sudden Death in ARVC

When VF is the endpoint, wait and see is not always the best option.

Ripolarizzazione precoce. Non così innocente come si pensava

Syncope in patients with inherited arrhythmogenic syndromes. Is it enough to justify ICD implantation?

Brugada Syndrome: An Update

Treatment of VT of Purkinje fiber origin: ablation targets and outcome

WPW and Brugada syndrome: what do they have in common?

Supraventricular arrhythmias in Brugada syndrome. Prof. Dr. Martin Borggrefe Mannheim

ARVC when TO IMPLANT THE ASYMPTOMATIC PERSON

J-wave syndromes: update on ventricular fibrillation mechanisms

The Role of Defibrillator Therapy in Genetic Arrhythmia Syndromes

ΔΠΔΜΒΑΣΙΚΗ ΘΔΡΑΠΔΙΑ ΚΟΙΛΙΑΚΩΝ ΑΡΡΤΘΜΙΩΝ

Clinical and Electrocardiographic Characteristics of Patients with Brugada Syndrome: Report of Five Cases of Documented Ventricular Fibrillation

Ripolarizzazione precoce.

Electrophysiologic investigation in Brugada syndrome

J Wave Syndromes. Osama Diab Lecturer of Cardiology Ain Shams University

ΤΙ ΠΡΕΠΕΙ ΝΑ ΓΝΩΡΙΖΕΙ ΟΓΕΝΙΚΟΣ ΚΑΡΔΙΟΛΟΓΟΣ ΓΙΑ ΤΙΣ ΔΙΑΥΛΟΠΑΘΕΙΕΣ

Ripolarizzazione precoce. Non così innocente come si pensava

WINDLAND SMITH RICE SUDDEN DEATH GENOMICS LABORATORY

Pearls of the ESC/ERS Guidelines 2015 Channelopathies

Low Risk for Arrhythmic Events in Asymptomatic Patients With Drug-Induced Type 1 ECG

Spontaneous type 1 pattern, ventricular arrhythmias and sudden cardiac death in Brugada Syndrome: an updated systematic review and meta-analysis

CME Article Brugada pattern masking anterior myocardial infarction

Case Presentation. Asaad Khan University College Hospital Galway Rep of Ireland

Risk Stratification in Patients With Brugada Syndrome Without Previous Cardiac Arrest

FANS Paediatric Pathway for Inherited Arrhythmias*

How to manage a patient with short QT syndrome?

Defibrillation threshold testing should no longer be performed: contra

Name of Presenter: Marwan Refaat, MD

Εμφύτευση απινιδωτών για πρωτογενή πρόληψη σε ασθενείς που δεν περιλαμβάνονται στις κλινικές μελέτες

Optimal management of Brugada syndrome

Asymptomatic Long QT. Prof. Dr. Martin Borggrefe Mannheim

Augmented ST-Segment Elevation During Recovery From Exercise Predicts Cardiac Events in Patients With Brugada Syndrome

Tachycardia Devices Indications and Basic Trouble Shooting

Brugada syndrome is a cardiac disease caused by an

Exercise guidelines in athletes with isolated repolarisation abnormalities and structurally normal heart.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY VOL. 65, NO. 9, 2015 ª 2015 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN /$36.

Idiopathic Ventricular Tachycardia Need for an Update in EHRA/HRS Consensus?

Outflow Tract Ventricular Tachycardia Always Benign?

Jean François Leclercq Department of Rythmology Private Hospital of Parly 2 - Le Chesnay F

DIAGNOSIS AND MANAGEMENT OF ARRHYTHMOGENIC CARDIOMYOPATHY. David SIU MD ( 蕭頌華醫生 ) Division of Cardiology The University of Hong Kong

Management of Syncope in Heart Failure. University of Iowa

Appearance of J wave in the inferolateral leads and ventricular fibrillation provoked by mild hypothermia in a patient with Brugada syndrome

First question: Does CRT Work in AF?

Professor Eric Schulze-Bahr

Subcutaneous Implantable Cardioverter Defibrillator (S-ICD)

Sudden death as co-morbidity in patients following vascular intervention

Low Prevalence of Risk Markers in Cases of Sudden Death Due to Brugada Syndrome

Vagally mediated ventricular arrhythmia in Brugada syndrome

PVCs: Do they cause Cardiomyopathy? Raed Abu Sham a, M.D.

Epicardial substrate ablation for Brugada syndrome

Synopsis of Management on Ventricular arrhythmias. M. Soni MD Interventional Cardiologist

ICD THERAPIES: are they harmful or just high risk markers?

The patient with (without) an ICD and heart failure: Management of electrical storm

How agressively should we treat asymptomatic patients with Brugada syndrome. Josep Brugada Medical Director Hospital Clínic, University of Barcelona

Heart Rhythm Disorders. How do you quantify risk?

Ventricular Arrhythmias

- Special VT Cases - Idiopathic Dilated Cardiomyopathy. D. Bänsch

The Brugada Syndrome: An Easily Identified and Preventable Cause of Sudden Cardiac Death

Reducing unnecessary and inappropriate therapy in secondary prevention patients

Electrical Storm in Coronary Artery Disease. Saeed Oraii MD, Cardiologist Interventional Electrophysiologist Tehran Arrhythmia Clinic July 2016

J Wave Syndrome: Clinical Diagnosis, Risk Stratification And Treatment Kamal K Sethi,Kabir Sethi,Surendra K Chutani

Sudden Cardiac Death and Asians Disclosures

Risk Stratification for Asymptomatic Patients With Brugada Syndrome

Asymptomatic WPW Syndrome; Observation or Ablation? 전남대학교병원순환기내과 박형욱

WPW in Athletes Should we treat all? age? RAMI FOGELMAN SCHNEIDER CHILDREN MEDICAL CENTER OF ISRAEL

Office ECG Interpretation

NAAMA s 24 th International Medical Convention Medicine in the Next Decade: Challenges and Opportunities Beirut, Lebanon June 26 July 2, 2010

P. Brugada 1, R. Brugada 2 and J. Brugada 3. Introduction. U.S.A.; 3 Unitat d Arritmias, Hospital Clinic, Barcelona, Spain

Interpretation and Consequences of Repolarisation Changes in Athletes

Πρώτης γραμμή θεραπεία η κατάλυση κοιλιακής ταχυκαρδίας στην ισχαιμική μυοκαρδιοπάθεια

The implantable cardioverter defibrillator is not enough: Ventricular Tachycardia Catheter Ablation in Patients with Structural Heart Disease

Positive QRS Complex in Lead I as a Malignant Sign in Right Ventricular Outflow Tract Tachycardia

Silvia G Priori MD PhD

Type 1 electrocardiographic burden is increased in symptomatic patients with Brugada syndrome

Prophylactic ablation

EPICARDIAL ABLATION IN GENETIC CARDIOMYOPATHIES: A NEW FRONTIER

The Electrophysiologic Mechanism of ST-Segment Elevation in Brugada Syndrome

Asymptomatic patient with WPW

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

Gender Differences in Clinical Manifestations of Brugada Syndrome

Ventricular Arrhythmia Induced by Sodium Channel Blocker in Patients With Brugada Syndrome

Tachycardias II. Štěpán Havránek

Antiarrhythmic Drugs and Ablation in Patients with ICD and Shocks

Accepted Manuscript. Eiichiro Nakagawa, M.D., Ph.D., Takahiko Naruko, M.D., Ph.D., Tosinori Makita, M.D., Ph.D

Abbreviation List: 2017 by the American Heart Association, Inc. and the American College of Cardiology Foundation. 1

The impact of clinical and genetic findings on the management of young Brugada Syndrome patients

Pattarapong Makarawate MD, FHRS Assistant Professor. Division Of Cardiology Faculty of Medicine, Khon Kaen University

Tailored therapy in long QT syndrome

Παναγιώτης Ιωαννίδης. Διευθυντής Τμήματος Αρρυθμιών & Επεμβατικής Ηλεκτροφυσιολογίας Βιοκλινικής Αθηνών

Ablative Therapy for Ventricular Tachycardia

The Brugada Syndrome*

Benign RVOT Ectopy and RV dysplasia

Atrial fibrillation in Cardiac Channelopathies

The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia

Transcription:

State of the Art: Brugada Syndrome Novel diagnostic approaches and risk stratification Lars Eckardt Division Electrophysiology Department of Cardiovascular Medicine University of Münster, Germany

I have nothing to disclose.

45 yr old male preoperative routine ECG asymptomatic FHx: 1 brother (SCD aged 45) 2 healthy brothers father died aged 85 (cancer) mother (79 years)

Prevalence-Estimations Brugada-ECG or Brugada-Sign Asian: 1:1000 (Denjoy et al, 2007) Caucasian: 5:1000 (Napolitano et al, 2006) Japanese: 14:1000 (Napolitano et al, 2006) Asia: 3.2 million Germany: 425.000 Japan: 1.820.000

Brugada Syndrome Nishizaki et al., Circulation Journal 2010

Correlation between diagnostic criteria and results of genetic screening in Brugada Syndrome.the appearance of a BrS pattern in the higher intercostals spaces or in only one precordial lead should be considered diagnostic in order to increase sensitivity without losing specificity. Vicentini, S. Castelletti,, R. Rordorf, P. Novara, M. Torchio, C. Dossena, S. Savastano, B. Petracci, L. Crotti, PJ Schwartz. University of Pavia, Division of Cardiology, Pavia

(Class II a) (Class II a) (Class I) (Class I) (Class II a) Antzelevitch et al., Circulation 2005; 111: 659-70

(Class II a) (Class II a) (Class I) (Class I) (Class II a) Antzelevitch et al., Circulation 2005; 111: 659-70

2009 2010 2011 Scientific publications on Brugada Syndrome It is time for a new consensus paper! n= 553 n= 1273 modified from Brugada et al., Hellenic J Cardiol 2009

Widespread use of prophylactic ICD is associated with intolerably high rates of complications Much longer survival of BS pts as compared to ICD pts with structural heart disease Sacher et al., Circ 2006 Rosso et al., Isr Med Assoc J 2008 J Cardiovasc Electrophysiol 2011

Asymptomatic individuals with an arrhythmic event during follow-up in different publications 3% 0.8% 1998 Paul et al., Eur Heart J 2007; 28: 2126-33

Asymptomatic individuals with an arrhythmic event during follow-up in different publications 3% 0.8% 1998 2002 Paul et al., Eur Heart J 2007; 28: 2126-33

Asymptomatic individuals with an arrhythmic event during follow-up in different publications 3% 0.8% 1998 2002 2003

Brugada et al., Circulation 2003

Mean follow-up: 40 50 months: n=9 VT/VF events!! VT/VF inducibility without predictive value!!! asymptomatic syncope SCD p=0.05 p=0.006 p=ns Non-inducible Inducible 93 75 60 43 31 15 93 83 57 35 20 13 Eckardt et al., Circulation 2005

n=9 VT/VF events during follow-up EP in all 9 pts - n=5 inducible (2 with one; 3 with 2 extra beats) - n=3 with a coupling interval < 200ms PVS 3 2 Extras sensitivity (%) 55.6 55.6 specificity (%) 50.3 59.9 I II III V1 V2 V3 positive predictive value (%) 5.4 6.6 negative predictive value (%) 95.7 96.4 Eckardt et al., Circulation 2005

Viskin and Rosso, JACC 2011 Outcomes of Patients With Asymptomatic Brugada Syndrome It can be concluded from these data that: - the risk for spontaneous VF at 4 to 5 years follow-up is likely between 1 and 6 % for asymptomatic individuals and inducible VF and -between 1% and 4% for asympt. pts and negative EPS - long term risk?? Kamakura et al., Circ EP 2009 Probst et al., Circ 2010

Brugada Syndrome risk stratification History of VF/VT or syncope Male Gender?? (testosterone) but 70% of asymp. are male (FINGER) Family History Genetic testing/mutation Spontaneous type 1 (coved type) ECG But high variability But not found in large Japanese registry Late potentials Early repola. pattern inferolat. leads ST elevation during recovery of exercise But test failed to indentify 68% of SCD QRS fragmentation in V1-V3 YES Perhaps Probably not Probably not Probably Perhaps Perhaps Perhaps Perhaps

Morita et al., Circulation 2008

Nademanee et al., Circulation 2011

Nademanee et al., Circulation 2011

3D-Electroanatomic Mapping-guided Endomyocardial Biopsy findings in patients with Brugada syndrome Maurizio Pieroni, MD, PhD..the identification of abnormal voltage areas and the corresponding myocardial substrate may influence both prognosis and treatment, including ablation strategies

Electro-anatomical mapping, biopsies.

Case V

Electro-anatomical mapping, biopsies. I II III avr avl avf V1 V2 V3 V4 V5 V6 B D C E Dechering et al., submitted

Circ 2004 Zhou et al., J Cardiovasc Dis Res, 2011

Risk vs Benefit of quinidine Quinidine often causes side effects (e.g. diarrhea) 1 of 3 discontinues drug? Low dose quinidine Proarrhythmia (aquired LQTS) close monitoring required!! http://www.brugadasyndrome.info/ Viscin et al., Heart Rhythm 2009

Subcutaneous-ICD 78,2 x 68,5 x 15,7 mm Volume: 70 cm³ Weight: 145 g Duration: ~ 5 yrs Maximal energy: 80 J Post-shock pacing 1 or 2 zones 170-250 bpm

Primary ICD prophylaxis in Brugada syndrome Syncope in the presence of Brugada ECG (IIA) Asymptomatic pts with a Brugada-ECG have a relatively low arrhythmogenic risk The accidental finding of a Brugada -ECG alone does not jusitfy ICD-implantation Programmed ventricular stimulation is of limited value for risk stratification (IIB) ACC/AHA/ESC Practice Guidelines Prevention of SCD 2006

Yann Arthus-Bertrand DIE ERDE VON OBEN Thank YOU